A daily struggle
The Vaccine Alliance will prioritize malaria and HPV drugs in 2023
Another goal is to immunize more than twelve million children who have not received any vaccines.
12/29/2022 07:26
Reading: 2′
2022-12-29T07:26:00-03:00
2022-12-29T07:26:00-03:00
Distribution of malaria and human papillomavirus (HPV) vaccines will be two of the top priorities the GAVI Alliance for Vaccines will address in 2023, its CEO Seth Berkley, who will step down in August next year, highlighted today .
Being able to immunize the more than 12 million children who do not have any vaccine doses is another major goal for the organization, which in 2020 received the Princess of Asturias Award for Cooperation.
Another priority Berkley cites in its year-end message is strengthening GAVI’s role in preparing for future pandemics, which the international community is strengthening by negotiating a potentially binding treaty by 2024.
“Global health is at a crossroads,” warned the head of the alliance, which through the COVAX program has distributed around 1,900 million doses of anticovid vaccines during the pandemic.
EFE extension
It may interest you
Lab-created monoclonal antibody could help prevent malaria
